2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 27885439 | Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis. | 2017 Jan | 1 |
| 2 | 28915617 | Predictive factors of pathologic complete response in HER2-positive and axillary lymph node positive breast cancer after neoadjuvant paclitaxel, carboplatin plus with trastuzumab. | 2017 Aug 22 | 2 |